Navigation LinksBiology NewsHealth NewsBiology TechnologyMedicine Technology


We're sorry, that page (http://www.bio-medicine.org/biology-news-1/;+health+history;+medical+history.html) was not found.

Search biology news 1 ;+health+history;+medical+history html at Google

Search biology news 1 ;+health+history;+medical+history html at Yahoo

Search biology news 1 ;+health+history;+medical+history html at Msn

Google
 
(Date:11/20/2009)... With the introduction of a single bacterial gene...Technology in the Netherlands achieved three impro... waste material: ,More ethanol, less acetate and e...week the invention was published in the scientific... , Car fuel , Bioethanol is made by the yeas...
(Date:11/20/2009)... Chronic obstructive pulmonary disease (COPD), a ...chitis or emphysema, is the fourth leading cause o...OPD and while researchers have yet to find any rea...arch Institute at The University of Western Ontari...niques to gain new insight into the disease. ,...
(Date:11/19/2009)... MADISON Roughly 15,000 years ago, at the end of... of large animals including such iconic creatures...oths and giant beavers began their precipitous sl...crashed, emptying a land whose diversity of large ...h Serengeti plains then or now, an entirely novel ...
Breaking Biology News(10 mins):Delft breakthrough in bioethanol production from agricultural waste 2Gaining a better picture of lung disease 2After mastodons and mammoths, a transformed landscape 2After mastodons and mammoths, a transformed landscape 3EUCODIS Bioscience to Explore Novel Enzymatic Activities in Antarctic Bacteria Library From Bio Sidus 14752 1EUCODIS Bioscience to Explore Novel Enzymatic Activities in Antarctic Bacteria Library From Bio Sidus 14752 2Oncolytics Biotech 28R 29 Inc Collaborators Present Positive Phase II Sarcoma Trial Results at CTOS Annual Meeting 14749 1Oncolytics Biotech 28R 29 Inc Collaborators Present Positive Phase II Sarcoma Trial Results at CTOS Annual Meeting 14749 2Oncolytics Biotech 28R 29 Inc Collaborators Present Positive Phase II Sarcoma Trial Results at CTOS Annual Meeting 14749 3Facet Solutions Acquires Archus Orthopedics 6054 1Facet Solutions Acquires Archus Orthopedics 6054 2
(Date:11/20/2009)...mber 20 in the Journal of the National Cancer Ins...that often appear in news coverage of cancer resea...media and journals to help alleviate the problem. ...hin, M.D., M.S., of Center for Medicine and the Me...nd Clinical Practice in New Hampshire, and Barnett...
(Date:11/20/2009)...ildren with chronic kidney disease often fail to d...sits increasing a child,s risk for serious heart ... Children,s Center and other institutions. A repor... American Society of Nephrology. , Researchers...ing regular doctor visits to readings obtained via...
(Date:11/20/2009)...of Dallas, TX, the new addition to blue sky scrubs...de in the USA. , Austin, ... an independent medical scrubs brand which focuses...distribution of hospital uniforms and surgical scr...a their online boutique, the Austin, TX business h...
(Date:11/20/2009)...g 90-day supply, study finds , , FRIDAY,...supply of prescription drugs is up to one-third ch... a new study. , U.S. researchers analyzed 26,85...and 2005, and found that patients who bought a thr...d an average 29 percent in out-of-pocket costs. Af...
(Date:11/20/2009)...s expected to continue, CDC says, , , F...he United States are seeing declines in H1N1 swine...ay, and while the disease remains widespread in 43...ast week. , "We are beginning to see some decli...there is still a lot of influenza everywhere," Dr....
Breaking Medicine News(10 mins):Health News:Promoting healthy skepticism in the news: Helping journalists get it right 2Health News:High blood pressure easy to miss in children with kidney disease 2Health News:Blue Sky Scrubs Secures a Second Texas Manufacturer 2Health News:Three-Month Supply Lowers Drug Costs 2Health News:Swine Flu Declining in Some Parts of U.S. 2Health News:Swine Flu Declining in Some Parts of U.S. 3
Mouse Anti-Human JRKL Monoclonal Antibody, Unconjugated, Clone 4E10 from Abnova Corporation
...ging system for detection of very low level of lum... extreme sensitive camera to detect low level ligh...us disease research, gene expression, circadian rh... with a motor-driven camera inside the light-tight...
... sets a new standard for high performance flow cyt...strumentation, this easy-to-use benchtop system de... The BD FACSAria instrument is the first benchtop ... flow cell. This new flow cell provides superior ...
Mouse Anti-Human IFNA13 Polyclonal Antibody, Unconjugated from Abnova Corporation
Biology Products:
DOVER ULTRAMER Foley Catheter
ULTRAMER Foley Catheters (Latex) 2-Way
DOVER Silicone Elastomer-Coated Latex Foley Catheters 3-Way
DOVER 100% Silicone Foley Catheters 2-Way (Pediatric)
Medicine Products:
(Date:11/20/2009)...TOLEDO recently announced that Dr. Dominique Hebra...f Process Analytical Technology (PAT) in Green Che... 2009. , (PRWEB) November...tical Technology (PAT) in Green Chemistry and Gree...ytical Technology (PAT) case studies will be prese...
(Date:11/19/2009)...swire-FirstCall/ -- Omeros Corporation (Nasdaq: O...for the third quarter ended September 30, 2009. Fo...s reported a net loss of $3.9 million, or $1.34 pe..., or $2.54 per share, for the same period in 2008.... Company reported a net loss of $15.5 million, or ...
(Date:11/19/2009)...wswire-FirstCall/ -- NeoStem, Inc. (NYSE Amex: NB...g letter to its shareholders, discussing the Compa...opharmaceuticals Holdings, Inc. (CHBP), an integra...,s Republic of China. The merger gives NeoStem a c...cal Co. Ltd., CHBP,s primary operating subsidiary ...
(Date:11/19/2009)..., November 19 MONITORING FORCE Gmb... 2009 Flibanserin in the,indication treatment-rele...sease for orphan drug status designation with the ... dyskinesia is a complication of the mainstay,trea... to some of those,affected, since it may be disabl...
Breaking Biology Technology:Process Analytical Technology (PAT) in Green Chemistry and Green Engineering 2Omeros Corporation Reports Third Quarter 2009 Financial Results and Development Highlights 2Omeros Corporation Reports Third Quarter 2009 Financial Results and Development Highlights 3Omeros Corporation Reports Third Quarter 2009 Financial Results and Development Highlights 4Omeros Corporation Reports Third Quarter 2009 Financial Results and Development Highlights 5Omeros Corporation Reports Third Quarter 2009 Financial Results and Development Highlights 6Omeros Corporation Reports Third Quarter 2009 Financial Results and Development Highlights 7Omeros Corporation Reports Third Quarter 2009 Financial Results and Development Highlights 8NeoStem Outlines to Shareholders Near-term and Long-term Business Strategies Following Acquisition of Chinese Pharmaceutical Company 2NeoStem Outlines to Shareholders Near-term and Long-term Business Strategies Following Acquisition of Chinese Pharmaceutical Company 3MONITORING FORCE GmbH Requests Acknowledgment of Flibanserin as "Orphan Drug" 2
(Date:11/20/2009)... 20 Reportlinker.com announces tha... catalogue. ,, Global Markets for Assisted Rep...inker.com/p0164742/Global-Markets-for-Assisted-Rep...amp;utm_medium=pr&utm_campaign=prnewswire ,...s the U.S., 15 Countries in Europe and Japan. This...
(Date:11/20/2009)... Cyberonics, Inc. (Nasda...nt and Chief Executive Officer, and Greg Browne, C...nnual Piper Jaffray Health Care Conference in New ...T. The conference session and webcast will be aud...iper Jaffray will host a webcast of the presentati...
(Date:11/20/2009)...Nov. 20 Soligenix, Inc. ...ny), formerly known as DOR BioPharma, Inc., a late... it has formed a consortium to develop thermostabl...y acting vaccines. Soligenix received a $9.4 milli...d Infectious Diseases (NIAID), a division of the N...
Breaking Medicine Technology:Reportlinker Adds Global Markets for Assisted Reproductive Devices 2009 2Cyberonics to Present at 21st Annual Piper Jaffray Health Care Conference 2Soligenix Forms Consortium to Develop Thermostable Technology to Advance RiVax(TM) and Other Rapidly Acting Vaccines 2Soligenix Forms Consortium to Develop Thermostable Technology to Advance RiVax(TM) and Other Rapidly Acting Vaccines 3Soligenix Forms Consortium to Develop Thermostable Technology to Advance RiVax(TM) and Other Rapidly Acting Vaccines 4Soligenix Forms Consortium to Develop Thermostable Technology to Advance RiVax(TM) and Other Rapidly Acting Vaccines 5Soligenix Forms Consortium to Develop Thermostable Technology to Advance RiVax(TM) and Other Rapidly Acting Vaccines 6James R Andrews Renowned Orthopaedic Surgeon Installed as AOSSM President 50355 1James R Andrews Renowned Orthopaedic Surgeon Installed as AOSSM President 50355 2James R Andrews Renowned Orthopaedic Surgeon Installed as AOSSM President 50355 3Cell Therapeutics Added to Russell 3000 28R 29 Russell 2000 28R 29 and Russell Global 28R 29 Indexes 12836 1Cell Therapeutics Added to Russell 3000 28R 29 Russell 2000 28R 29 and Russell Global 28R 29 Indexes 12836 2Cell Therapeutics Added to Russell 3000 28R 29 Russell 2000 28R 29 and Russell Global 28R 29 Indexes 12836 3Pharmaxis Closes Share Purchase Plan 12835 1Pharmaxis Closes Share Purchase Plan 12835 2